AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Atlantic Sapphire

Quarterly Report Sep 19, 2019

3543_rns_2019-09-19_e5540e5a-657c-432b-a25b-efd9862f24a2.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Atlantic Sapphire AS

Interim Consolidated Financial Statements

June 30, 2019

In accordance with International Financial Reporting Standards

Statement by Management and the Board of Directors on June 30, 2019 Interim Financial Statements

Management and the Board of Directors have today considered and approved the interim report of Atlantic Sapphire AS for the period 1 January 2019 to 30 June 2019. The interim report, which has not been audited or reviewed by the company's independent auditors, has been prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the EU disclosure requirements for listed companies. In our opinion, the accounting policies used are appropriate, and the interim report gives a true and fair view of the Group's financial position at 30 June 2019, as well as the results of the Group activities and cash flows for the period 1 January 2019 to 30 June 2019. In our opinion, Management's review provides a true and fair presentation of developments, results for the period, and overall financial position of the Group operations in addition to a description of the most significant risks and elements of uncertainty facing the Group. Over and above the disclosures in the interim report, no changes in the Group's most significant risks and uncertainties have occurred relative to the disclosures in the annual report for 2018.

Vikebukt, 16 September 2019

Johan E. Andreassen Chairman of the Board and Chief Executive Officer

Bjørn-Vegard Løvik Henrik Krefting Board member Board member

Andre Skarbø Alexander Reus Board member Board member

Patrice Flanagan Board member

Peter Allan Skou Board member

Consolidated Income Statement

Period ended 30 June

(USD 1,000) Note 2019 2018
Revenue 2 2,021 4
Other income 3 0
Revenue and other income 2,024 4
Cost of materials 2,187 10
Fair value adjustment on biological assets 3 -704 -171
Salary and personnel costs 1,643 1,034
Other operating expenses 3,423 3,412
Depreciation and amortization 4 1,039 369
Total operating expenses 7,588 4,655
Operating income/(loss) -5,564 -4,650
Financial income 183 635
Financial expenses -4,062 -2,020
Financial income/(expenses) - net -3,879 -1,385
Profit/loss before income tax -9,443 -6,035
Income tax expense - -
Profit/(loss) for the year -9,443 -6,035
Loss is attributable to:
Owners of Atlantic Sapphire AS -9,443 -6,035
Profit/(loss) for the year -9,443 -6,035
Earnings per share:
Basic earnings per share -0.15 -0.12
Diluted earnings per share -0.15 -0.12

Consolidated Statement of Comprehensive Income

Period ended
30 June
2018
-6,035
-2,356
-6,828 -8,391
-8,391
-6,828 -8,391
Note 2019
-9,443
2,615
-6,828

Consolidated Statement of Financial Position

(USD 1,000) Note 30.06.2019 31.12.2018
ASSETS
Non-current assets
Property, plant and equipment 4 170,185 126,300
Intangible assets 174 103
Investments in other companies 11 11
Trade and other receivables - non-current 275 20
Total non-current assets 170,645 126,433
Current assets
Prepaid expenses 1,215 1,976
Inventories 155 105
Biological assets 3 7,386 3,283
Trade and other receivables - current 1,683 1,097
Cash and cash equivalents 5 81,015 19,018
Total current assets 91,454 25,478
TOTAL ASSETS 262,099 151,912
EQUITY AND LIABILITIES
Equity
Share capital 7 836 720
Share premium 7 242,099 151,765
Other equity -26,799 -15,045
Total equity 216,136 137,439
Non-current liabilities
Borrowings - non-current 6 27,135 904
Total non-current liabilities 27,135 904
Current liabilities
Borrowings - current 67 190
Trade and other payables 18,761 13,378
Total current liabilities 18,828 13,568
Total liabilities 45,963 14,472
TOTAL EQUITY AND LIABILITIES 262,099 151,912

Consolidated Statement of Cash Flows

Period ended
(USD 1,000) Note 2019 2018
Cash flow from operating activities
Loss before tax -9,443 -6,035
Adjustments for
Taxes paid - -
Depreciation, amortization and net impairment losses 4 1,039 369
Non-cash - share based payments 411 51
Net fair value adjustment on biological assets 3 -704 -171
Net interest paid and received 1,730 667
Net exchange differences -165 -719
Change in operating assets and liabilities
Inventories (and biomass at cost) -3,467 -1,023
Change in trade and other receivables -894 978
Change in trade and other payables -467 1,688
Change in prepaid expenses 761 -1,135
Interest received - 169
Net cash outflow from operating activities -11,199 -5,160
Cash flow from investing activities
Payment for property, plant and equipment -39,032 -41,903
Net cash outflow from investing activities -39,032 -41,903
Cash flow from financing activities
Proceeds from issuance of ordinary shares 87,683 71,690
Proceeds from borrowings, net of debt issuance costs 39,544 110
Repayment of borrowings -13,621 -128
Interest paid -1,543 -836
Net cash inflow from financing activities 112,063 70,836
Net increase/(decrease) in cash and cash equivalents 61,832 23,772
Cash and cash equivalents 1 January 19,018 53,069
Effects of exchange rate changes on cash and cash equivalents 165 107
Cash and cash equivalents 30 June 81,015 76,948

Consolidated Statement of Changes in Equity

Attributable to the owners of the parent
Share Share Translation Retained Total
(USD 1.000) Note Capital Premium Differences Earnings Equity
Balance at 1 January 2018 564 91,312 3,608 -14,177 81,307
Loss for the period -6,035 -6,035
Currency translation differences -5 -2,237 -2,356 2,242 -2,356
Contribution of equity net of
transaction costs 207 72,467 72,674
Option program 51 51
Balance at 30 June 2018 766 161,541 1,252 -17,918 145,641
Balance at 1 January 2019 720 151,765 -1,669 -13,376 137,439
Loss for the period -9,443 -9,443
Currency translation differences 16 4,988 2,615 -5,004 2,615
Contribution of equity net of
transaction costs 7 100 85,346 85,446
Option program 79 79
Balance at 30 June 2019 836 242,099 946 -27,745 216,136

Notes to the financial statements

Note 1 - Summary of Significant Accounting Policies

This consolidated interim financial report for the half-year reporting period ended 30 June 2019 has been prepared in accordance with International Financial Reporting Standards (IFRS), including the accounting standard IAS 34 Interim Financial Reporting.

This consolidated interim financial report does not include all the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the annual report for the year ended 31 December 2018 and any public announcements made by Atlantic Sapphire AS during the interim reporting period.

The accounting policies adopted are consistent with those of the previous financial year.

Note 2 - Segments

(USD 1,000)

The group's executive management and Board of Directors examines the group's performance on a total level and by farming site and has identified two reportable segments of its business:

Fish farming Denmark The group own and operate a land-raised salmon farm in
Denmark. The principal activities comprise of production and
sale of salmon.
Fish farming USA The group is building a land-raised salmon farm in Miami
Dade county, Florida. Phase one is under construction and
is expected to be complete in 2020.

The activities of the parent company are presented together with eliminations.

In the tables below we show segment information and the disaggregation of revenue.

Half year ended June 30, 2019

Fish farming Other and
Norway Denmark USA eliminations Consolidated
Revenue - 2,021 - - 2,021
EBITDA -435 -886 -2,793 -411 -4,525
Pre-tax profit or loss -1,630 -2,538 -4,501 -774 -9,443
Total assets 243,784 42,651 172,062 -196,398 262,099
Total liabilities 110 35,037 43,928 -33,112 45,963
Depreciation and amortization - 1,000 39 - 1,039
Capital expenditure - 3,451 41,648 - 45,099

Half year ended June 30, 2018

Fish farming Other and
Norway Denmark USA eliminations Consolidated
Revenue - 4 - - 4
EBITDA -579 -652 -3,761 711 -4,281
Pre-tax profit or loss -1,362 -1,437 -3,747 511 -6,035
Total assets 162,616 28,946 63,512 -103,162 151,912
Total liabilities 91 24,354 10,913 -20,886 14,472
Depreciation and amortization - 342 27 - 369
Capital expenditure - 9,334 32,771 - 42,105

Revenue

The Group derives the following types of revenue: 6/30/2019 6/30/2018
Salmon 2,021 4
Geographical information
Revenue from external customers in: 6/30/2019 6/30/2018
Denmark 397 0
USA 151 0
Europe 1,473 4
Total 2,021 4
Major customers 6/30/2019 6/30/2018
Customer A 1,196 4
Customer B 353 -
Customer C 151 -
Other customers 321 -
Total 2,021 4

Note 3 - Biological Assets

(USD 1,000)

Reconciliation of changes in the carrying amount 6/30/2019 6/30/2018
Carrying amount, opening balance 3,283 280
Gain or loss arising from changes in fair value less costs to sell 704 171
Increases due to production and purchases 5,327 1,045
Decreases due to harvest -1,661 -
Decreases due to mortality -257 -16
Net exchange rate differences -10 -50
Carrying amount, closing balance 7,386 1,430

Note 4 - Property, Plant & Equipment

(USD 1,000)

Land Buildings Production,
Plant &
Machinery
Equipment
and Other
Movables
Construction
in Progress
Total
At 1 January 2019
Cost 3,691 10,221 21,594 695 93,261 129,462
Accumulated depreciation - -686 -2,271 -204 - -3,161
Net book amount 3,691 9,535 19,323 491 93,261 126,301
Year ended 30 June 2019
Opening net book amount 3,691 9,535 19,323 491 93,261 126,301
Additions - 3,330 - 243 41,526 45,099
Reclassifications - 363 - - -363 -
Disposals - - - - - -
Depreciation charge - -247 -724 -68 - -1,039
Reversed depreciation - - - - - -
Impairment loss - - - - - -
Net exchange rate differences - -54 -116 -1 -5 -176
Closing net book amount 3,691 12,927 18,483 665 134,419 170,185
At 30 June 2019
Cost 3,691 13,857 21,470 936 134,420 174,374
Accumulated depreciation - -931 -2,987 -271 - -4,189
Net book amount 3,691 12,926 18,483 665 134,420 170,185
Economic life 18-24 10-15 5
Depreciation plan Linear Linear Linear
Land Buildings Production,
Plant &
Machinery
Equipment
and Other
Movables
Construction
in Progress
Total
At 1 January 2018
Cost 1,732 2,561 6,747 394 26,798 38,232
Accumulated depreciation - -493 -1,771 -102 - -2,366
Net book amount 1,732 2,068 4,976 292 26,798 35,866
Year ended 30 June 2018
Opening net book amount 1,732 2,068 4,976 292 26,798 35,866
Additions 1,959 3 16 254 39,873 42,105
Reclassifications - - - - - -
Disposals - - - - - -
Depreciation charge - -60 -262 -48 - -370
Reversed depreciation - - - - - -
Impairment loss - - - - - -
Net exchange rate differences - -52 -122 -5 -515 -694
Closing net book amount 3,691 1,959 4,608 493 66,156 76,907
At 30 June 2018
Cost 3,691 2,497 6,584 639 66,156 79,567
Accumulated depreciation - -537 -1,977 -146 - -2,660
Net book amount 3,691 1,960 4,607 493 66,156 76,907
Economic life 18-24 10-15 5
Depreciation plan Linear Linear Linear

Note 5 - Bank Deposits

(USD 1,000)

6/30/2019 6/30/2018
Cash in bank 65,706 18,716
Cash equivalents 15,309 302
Total cash and cash equivalents 81,015 19,018

Restricted cash

The following deposits are subject to regulatory and credit facility restrictions and are therefore not available for general use.

6/30/2019 6/30/2018
Taxes withheld - -
Other restricted cash 15,309 302
Total restricted cash 15,309 302

Not

Note 7 - Equity Financing

On 8 May 2019, the Company raised approximately NOK 783m (~USD 90m) in gross proceeds through a private placement of 8,464,864 new shares, at a price per share of NOK 92.50, which is approximately equal to the last closing price on 7 May 2019. Net proceeds from the transaction were NOK 747m (~USD85m).

Note 8 - Subsequent Events

On 18 July 2019, the Company purchased an additional 80 acres of land in Miami-Dade county, Florida for \$5m to support the expansion of production capacity in the US.

Talk to a Data Expert

Have a question? We'll get back to you promptly.